SETD2 and nonpapillary renal cell carcinoma: For instance, both full loss of 3p and focal loss of events along 3p21-p25 (VHL, PBRM1, BAP1, SETD2) are counted as ‘arm-level’ in the ccRCC characterization from the Cancer Genome Atlas Research Network4.